Global Therapeutic Protein Market Size Analysis 2022, Top Regions, Key Players and Investments Opportunities Forecast to 2028

The global therapeutics protein market is anticipated to grow at a significant CAGR 2% during the forecast period (2022-2028). Therapeutic proteins are medicines that are genetically engineered versions of naturally occurring human proteins. The rise in the prevalence of chronic diseases such as cancer, diabetes, and others is anticipated to drive the growth of the global therapeutics protein market. For instance, according to IDF Diabetes Atlas Tenth Edition 2021, approximately 537 million people, between the age of 20-79 years are living with diabetes and the total number is projected to rise to 643 million by 2030, 783 million by 2045. More than 1.2 million children and adults are living with type -1 diabetes and 541 million adults are at an increased risk of developing type -2 diabetes According to IDF, diabetes has caused more than 6.7 million deaths globally. Thus, the rise in the prevalence of diabetes is anticipated to drive the demand of the therapeutic protein market during the forecast period.

Looking towards the demand for therapeutic protein, key market players are adopting various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in January 2022, Amgen Inc. and Generate Biomedicines collaborated to discover and create protein therapeutics for five clinical targets across several therapeutic areas.

As a part of the collaboration, Amgen will pay $50 million upfront funding for the initial 5 programs with a transaction value of $1.9 billion and will have the option to nominate up to five additional programs, at additional cost. For each program, Amgen will pay $370 million in future milestones. Further, Amgen is also set to participate in future financing rounds for Generate Biomedicines. Thus, such strategic collaborations are anticipated to drive the growth of the therapeutic protein market during the forecast period

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Abbott Laboratories, Amgen Inc., Baxter International Inc., and Eli Lilly & Co. among others

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Therapeutic Protein Market Report by Segment

By Type

• Insulin
• Fusion Protein
• Erythroprotein
• Interferon
• Human Growth Hormone
• Follicle Stimulating Hormone
• Others

By Application

• Metabolic Disorders
• Immunologic Disorders
• Cancer Hormonal Disorder
• Genetic Disorders

By End-User

• Pharmaceutical Companies
• Health Care Service Providers
• Academic and Research Organizations

Global Therapeutic Protein Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa